InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+30.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Evanson Jeff, Directeur Commercial. Officer active across 1 company, notably Outlook Therapeutics, Inc.. Aggregated, 4 reports have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €372k. Activity tracked since 3 December 2021. The latest transaction was disclosed on 7 March 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Evanson Jeff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
62,484 shares@ US$0.425.8% of flowCommon StockSEC:0001415889-24-007516:0
Canonical exit: 5 Jun 2024 (T+90)
267,000 shares@ US$1.1166.1% of flowCommon StockSEC:0001209191-23-004732:0
27,162 shares@ US$1.317.9% of flowCommon StockSEC:0001209191-23-004118:0
35,200 shares@ US$1.3411.2% of flowCommon StockSEC:0001209191-21-068134:0
Canonical exit: 3 Mar 2022 (T+90)
4 of 4 declarations
About Evanson Jeff
Jeff Evanson is the Chief Commercial Officer at Outlook Therapeutics, Inc. He is responsible for business strategy and development. His role includes identifying market opportunities and managing sales teams.
